Skip to main content

Table 1 Sociodemographic data and presence of anti-NMDA receptor antibody in the control and patient groups of the study

From: N-Methyl-d-aspartate (NMDA) receptor antibody in relation to autism spectrum disorder (ASD): presence and association with symptom profile

Parameter Group Test of significance
Control (N = 60) Case (N = 87)
Mean ± SD Mean ± SD Value p-value Sig.
N (%) N (%)
Age- months 80.53 ± 29.71 79.45 ± 29.95 t = 2.944 0.568(T) NS
Gender Male 48 (80%) 69 (79.31%) X2 = 0.01 0.919(C) NS
Female 12 (20%) 18 (20.69%)
Anti-NMDA receptor antibody Present 0 (0%) 23 (26.4%)   0.0157(C) S
Absent 60 (100%) 64 (73.6%)
  1. SD Standard deviation, N Number, S Significant, NS Not significant, (T)Student’s t-test of significance (t = Student’s t-test value). (C)Chi-Square test of significance (X2 = chi-square test value)